SCHEMBL34466050

SCHEMBL34466050

CC1c2c3cc(Br)c(Cl)c(Cl)c3nn2CCN1C(=O)OC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.34
▸ NR1H2 P55055 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ UCHL1 P09936 2/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ USP30 Q70CQ3 3/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ NR1H3 Q13133 1/20 0.32
▸ CNR1 P21554 2/20 0.31
▸ SETD7 Q8WTS6 1/20 0.31
▸ SUV39H2 Q9H5I1 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ STS P08842 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34465741 0.91 UCHL1 (0.33) GRM5NR1H2ALDH1A1UCHL1MAP4K4
SCHEMBL34466888 0.91 UCHL1 (0.33) GRM5NR1H2ALDH1A1UCHL1MAP4K4
SCHEMBL35210758 0.88 SUV39H2 (0.37) GRM5ALDH1A1MAP4K4MEN1KMT2A
SCHEMBL35211325 0.88 SUV39H2 (0.37) GRM5ALDH1A1MAP4K4MEN1KMT2A
SCHEMBL34466640 0.88 SUV39H2 (0.37) GRM5ALDH1A1MAP4K4MEN1KMT2A
SCHEMBL26130129 0.84 GRM5 (0.36) GRM5ALDH1A1MAP4K4OPRK1MEN1
SCHEMBL34466128 0.82 GRM5 (0.33) GRM5NR1H2ALDH1A1MAP4K4USP30
SCHEMBL34466163 0.82 GRM5 (0.33) GRM5NR1H2ALDH1A1MAP4K4USP30
SCHEMBL34466671 0.82 ALDH1A1 (0.34) ALDH1A1OPRK1MEN1LMNAMAPT
SCHEMBL35211102 0.81 TLR9 (0.35) GRM5ALDH1A1USP30LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108509-A1 6-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260108509-A1 6-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF CGAS, GBA3, GBA1 GRM5 4003/4885NR1H2 614/4885ALDH1A1 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback